After 30 years, scientists finally have a drug for a deadly brain disease

The FDA has approved Zanvastro, the first drug directly targeting Alexander disease, a rare neurological disorder affecting fewer than one in a million people. According to the report, the drug, developed through decades of research, showed promising clinical trial results, stabilizing motor function and even improving movement in some patients.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.